[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@medtechmd Avatar @medtechmd Will

Will posts on X about $xene, $kura, $lnth, target the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence stocks XXXXX% finance XXXX%

Social topic influence $xene #3, $kura #3, $lnth #3, target 12.5%, $xyl #4, $gehc 4.17%, $rapp 4.17%, year of 4.17%, achieving 4.17%, $abt XXXX%

Top accounts mentioned or mentioned by @drtanwp @jamiespakand @nyulangone @focalonehifu @benioff @amarukishan

Top assets mentioned Xenon Pharmaceuticals Inc (XENE) Lantheus Holdings, Inc (LNTH) Xylem Inc (XYL) GE HealthCare Technologies Inc. Common Stock (GEHC) Arcblock (ABT) Morgan Stanley (MS) TransMedics Group, Inc. Common Stock (TMDX) Biohaven Pharmaceutical Holding Company Ltd. (BHVN)

Top Social Posts

Top posts by engagements in the last XX hours

"Positive comments from RSNA Regarding $LNTH Pylarify & $GEHC/$LNTH Flyrcado"
X Link 2025-12-03T11:34Z XXX followers, XXX engagements

"Water management becomes mainstream: $XYL"
X Link 2025-10-28T11:03Z XXX followers, XXX engagements

"Jefferies comments regarding $XENE & $RAPP for data/presentations at American Epilepsy Society 12/5-9"
X Link 2025-11-29T13:14Z XXX followers, XXX engagements

"Jefferies latest comments on $KURA & competitive landscape with data due at ASH 2025"
X Link 2025-12-02T18:30Z XXX followers, XXX engagements

"$KURA : $XXXXX Price Target"
X Link 2025-11-24T13:07Z XXX followers, 1200 engagements

"$XENE Showcases New 48-Month Azetukalner OLE Study Data in Epilepsy at AES 2025. Monthly reductions in seizure frequency of XXXX% among participants treated for XX months in the OLE with XX% achieving X year of seizure freedom"
X Link 2025-12-05T14:21Z XXX followers, XXX engagements

"$XENE Azetukalner Continues Excellent Safety & Efficacy Advantages In X Year Focal Epilepsy Indication"
X Link 2025-12-08T00:52Z XXX followers, XXX engagements

"Abbott Labs : $ABT : FreeStyle Libre"
X Link 2025-06-24T18:42Z XXX followers, 2586 engagements

"Morgan Stanley Underestimates $TMDX Role In Transforming The Organ Transplant Dynamic In The US And Abroad"
X Link 2025-12-02T11:47Z XXX followers, 2706 engagements

"$XYL raises revenue and EPS as water management becomes mainstream"
X Link 2025-10-28T11:04Z XXX followers, XXX engagements

"Jefferies Maintains $XXX Price Target On $LNTH"
X Link 2025-11-06T19:09Z XXX followers, XXX engagements

"With earlier approval $KURA is ready to launch within days only 2-3wks behind key comp and expects to take sig market share based on favorable overall profile/FDA label and market research"
X Link 2025-11-13T20:43Z XXX followers, 12.8K engagements

"Jefferies commentary $KURA Ziftomenib vs competitor. Price Target $XXXXX. Ziftos once-daily dosing absence of clinically meaningful DDI and cleaner combinability position it better for sequencing with VEN/AZA FLT3 inhibitors and future triplets"
X Link 2025-11-20T03:57Z XXX followers, 5416 engagements

"$BHVN Downgrade: The immediate value in Biohaven's pipeline comes from Kv7 but the company is two years behind competitor $XENE in the primary indication the analyst tells investors in a research note"
X Link 2025-11-26T11:21Z XXX followers, XXX engagements

"$LNTH PNT2002 Along W/Stereotactic Body Radiotherapy Resulted In Significantly Improved PFS In Recurrent Prostate Cancer"
X Link 2025-12-07T18:02Z XXX followers, XXX engagements

"$XENE Four Year Data Focal Epilepsy: Jefferies Comments Post AES"
X Link 2025-12-08T00:54Z XXX followers, XXX engagements